Patrick John Finn - Dec 29, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Commercial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
Stock symbol
TWST
Transactions as of
Dec 29, 2021
Transactions value $
-$400,399
Form type
4
Date filed
12/30/2021, 04:00 PM
Previous filing
Dec 29, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $52.9K +5.99K +13.53% $8.82 50.3K Dec 29, 2021 Direct
transaction TWST Common Stock Sale -$453K -5.99K -11.92% $75.62 44.3K Dec 29, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -5.99K -64.64% $0.00 3.28K Dec 29, 2021 Common Stock 5.99K $8.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 16, 2021.
F2 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.